RNASE2 and chronic myelogenous leukemia, BCR-ABL1 positive: As an immune-related molecule, RNASE2 is a biomarker of various immune system diseases, including chronic myelogenous leukemia, systemic lupus erythematosus, rheumatoid arthritis, and multiple myeloma30–33.